Clinical Trial Detail

NCT ID NCT04389632
Title A Study of SGN-B6A in Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Seattle Genetics, Inc.
Indications

urinary bladder cancer

breast cancer

esophageal cancer

skin squamous cell carcinoma

head and neck squamous cell carcinoma

stomach cancer

lung non-small cell carcinoma

ovarian cancer

pancreatic adenocarcinoma

cervical cancer

Therapies

SGN-B6A

Age Groups: adult senior

No variant requirements are available.